90 related articles for article (PubMed ID: 7985058)
21. [Resistance to activated protein C. The most common cause of familial thrombophilia].
Larsen TB; Ravn HB; Lassen JF; Lund ED; Brandslund I
Ugeskr Laeger; 1996 Nov; 158(46):6584-8. PubMed ID: 8966822
[TBL] [Abstract][Full Text] [Related]
22. Is plasminogen deficiency a thrombotic risk factor? A study on 23 thrombophilic patients and their family members.
Demarmels Biasiutti F; Sulzer I; Stucki B; Wuillemin WA; Furlan M; Lämmle B
Thromb Haemost; 1998 Jul; 80(1):167-70. PubMed ID: 9684804
[TBL] [Abstract][Full Text] [Related]
23. Plasma resistance to activated protein C in venous and arterial thrombosis.
Cushman M; Bhushan F; Bovill E; Tracy R
Thromb Haemost; 1994 Oct; 72(4):647. PubMed ID: 7878648
[No Abstract] [Full Text] [Related]
24. [Phlebothrombosis and pulmonary thromboembolism in patients with thrombophilia].
Karpenko AA; Gervaziev VB; Barkagan ZS; Tsyvkina LP
Angiol Sosud Khir; 2007; 13(1):59-64. PubMed ID: 17679975
[TBL] [Abstract][Full Text] [Related]
25. [Recurrent thromboembolism disclosing protein C deficiency. Apropos of a case with familial investigation].
Jonot F; Pouchelon E; Cambus JP; Bierme R; Leophonte P
Rev Pneumol Clin; 1990; 46(5):221-4. PubMed ID: 2075365
[TBL] [Abstract][Full Text] [Related]
26. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease.
Novacek G; Miehsler W; Kapiotis S; Katzenschlager R; Speiser W; Vogelsang H
Am J Gastroenterol; 1999 Mar; 94(3):685-90. PubMed ID: 10086652
[TBL] [Abstract][Full Text] [Related]
27. [Study of hemostasis in patients with a recent thromboembolic complication].
Samama MM
Arch Mal Coeur Vaiss; 1995 Nov; 88(11 Suppl):1793-7. PubMed ID: 8815842
[TBL] [Abstract][Full Text] [Related]
28. [Risk factors of venous thromboembolism].
Barczyk A; Pierzchała W
Wiad Lek; 2001; 54(5-6):311-24. PubMed ID: 11556214
[TBL] [Abstract][Full Text] [Related]
29. Activated protein C levels in Behçet's disease and risk of venous thrombosis.
Navarro S; Ricart JM; Medina P; Vayá A; Villa P; Todolí J; Estellés A; Micó ML; Aznar J; España F
Br J Haematol; 2004 Aug; 126(4):550-6. PubMed ID: 15287949
[TBL] [Abstract][Full Text] [Related]
30. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
Dahlbck B
J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
[TBL] [Abstract][Full Text] [Related]
31. Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency.
Zöller B; Holm J; Svensson P; Dahlbäck B
Thromb Haemost; 1996 Feb; 75(2):270-4. PubMed ID: 8815575
[TBL] [Abstract][Full Text] [Related]
32. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
Gessoni G; Valverde S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
[TBL] [Abstract][Full Text] [Related]
33. Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis.
Gschwandtner ME; Eichinger S; Hütter D; Korninger L; Lechner K; Panzer S; Pabinger I
Blood Coagul Fibrinolysis; 1996 Apr; 7(3):325-30. PubMed ID: 8735139
[TBL] [Abstract][Full Text] [Related]
34. Thrombophilia testing in patients with venous thrombosis.
Caprini JA; Goldshteyn S; Glase CJ; Hathaway K
Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):550-5. PubMed ID: 16055356
[TBL] [Abstract][Full Text] [Related]
35. Laboratory identification of conditions predisposing to thrombosis.
Sanfelippo MJ; Caya JG
Wis Med J; 1990 Nov; 89(11):635-8. PubMed ID: 2148045
[TBL] [Abstract][Full Text] [Related]
36. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
[TBL] [Abstract][Full Text] [Related]
37. [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].
Bauersachs R; Lindhoff-Last E; Ehrly AM; Kuhl H
Zentralbl Gynakol; 1996; 118(5):262-70. PubMed ID: 8701622
[TBL] [Abstract][Full Text] [Related]
38. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
[TBL] [Abstract][Full Text] [Related]
39. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
40. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease.
Mader R; Ziv M; Adawi M; Mader R; Lavi I
J Rheumatol; 1999 Nov; 26(11):2404-8. PubMed ID: 10555901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
